Discussion Topic | Replies (estimated) | Archive Link |
Citation needed | 5 | Talk:Fluvoxamine/Archive 1#Citation needed |
Cleanup, references and WP:NPOV | 1 | Talk:Fluvoxamine/Archive 1#Cleanup, references and WP:NPOV |
Historical relevance | 1 | Talk:Fluvoxamine/Archive 1#Historical relevance |
effect of luvox on the brain | 1 | Talk:Fluvoxamine/Archive 1#effect of luvox on the brain |
SSRI | 1 | Talk:Fluvoxamine/Archive 1#SSRI |
Manufacturers | 1 | Talk:Fluvoxamine/Archive 1#Manufacturers |
Ciprofloxacine | 1 | Talk:Fluvoxamine/Archive 1#Ciprofloxacine |
Paedophilia | 1 | Talk:Fluvoxamine/Archive 1#Paedophilia |
Longest half-life? | 1 | Talk:Fluvoxamine/Archive 1#Longest half-life? |
Bioavailability inconsistency | 1 | Talk:Fluvoxamine/Archive 1#Bioavailability inconsistency |
Chemical name | 1 | Talk:Fluvoxamine/Archive 1#Chemical name |
Fluvoxamine connected to circadian rhythm sleep disorders, as distinguished from other SSRIs. | 3 | Talk:Fluvoxamine/Archive 1#Fluvoxamine connected to circadian rhythm sleep disorders, as distinguished from other SSRIs. |
Countries | 2 | Talk:Fluvoxamine/Archive 1#Countries |
Largest manufacturer | 1 | Talk:Fluvoxamine/Archive 1#Largest manufacturer |
Fluoride content and bioavailability of Fluoride from Fluvoxamine, compared to fluoride from drinking water and food? | 1 | Talk:Fluvoxamine/Archive 1#Fluoride content and bioavailability of Fluoride from Fluvoxamine, compared to fluoride from drinking water and food? |
Information on use for treating COVID | 23 | Talk:Fluvoxamine/Archive 1#Information on use for treating COVID |
Contradictory information on the strength of Fluvoxamine's inhibition of CYP2D6 | 2 | Talk:Fluvoxamine/Archive 1#Contradictory information on the strength of Fluvoxamine's inhibition of CYP2D6 |
Suggestions for Additions | 1 | Talk:Fluvoxamine/Archive 1#Suggestions for Additions |
Dashes | 1 | Talk:Fluvoxamine/Archive 1#Dashes |
Puff claim not in cite | 1 | Talk:Fluvoxamine/Archive 1#Puff claim not in cite |
Unconsummated citations | 1 | Talk:Fluvoxamine/Archive 1#Unconsummated citations |
Efficacy numbers against COVID-19 hospitalization: undue? | 6 | Talk:Fluvoxamine/Archive 1#Efficacy numbers against COVID-19 hospitalization: undue? |
Additional Covid sources | 1 | Talk:Fluvoxamine/Archive 1#Additional Covid sources |
Elimination half-life. 12-13 hours for single dose, 22 hours for repeated dosing | 1 | Talk:Fluvoxamine#Elimination half-life. 12-13 hours for single dose, 22 hours for repeated dosing |
Sentence under society and culture | 4 | Talk:Fluvoxamine#Sentence under society and culture |
Sourcing | 3 | Talk:Fluvoxamine#Sourcing |
ACTIV-6 | 4 | Talk:Fluvoxamine#ACTIV-6 |